Burning Rock Q4 net loss narrows 81% to RMB15.4 million as cost of revenues falls 24% to RMB27.7 million

Reuters03-12 19:09

Burning Rock Q4 net loss narrows 81% to RMB15.4 million as cost of revenues falls 24% to RMB27.7 million

Burning Rock reported Q4 2025 revenue of RMB126.3 million, up 10% in gross profit to RMB98.57 million. Q4 net loss narrowed to RMB15.4 million from a year earlier, while operating expenses fell 36% to RMB110.6 million due to budget control measures including headcount reduction. In Q4, central laboratory revenue rose 12% to RMB44 million on higher CanCatch test volumes, while in-hospital revenue increased 17% to RMB51 million driven by higher sales volume from existing hospitals and new contracted partner hospitals. For FY 2025, revenue increased 5% to RMB539.57 million and net loss narrowed to RMB55.35 million. FY 2025 pharma research and development services revenue rose 35% to RMB155.5 million on increased development and testing services for pharma customers, while cash, cash equivalents and restricted cash totaled RMB481.09 million as of Dec. 31, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Burning Rock Biotech Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603120708PRIMZONEFULLFEED9670857) on March 12, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2618411136?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 19:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618411136","market":"us","top_or_hot":-1,"title":"Burning Rock Q4 net loss narrows 81% to RMB15.4 million as cost of revenues falls 24% to RMB27.7 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Burning Rock Q4 net loss narrows 81% to RMB15.4 million as cost of revenues falls 24% to RMB27.7 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Burning Rock reported Q4 2025 revenue of RMB126.3 million, up 10% in gross profit to RMB98.57 million. Q4 net loss narrowed to RMB15.4 million from a year earlier, while operating expenses fell 36% to RMB110.6 million due to budget control measures including headcount reduction. In Q4, central laboratory revenue rose 12% to RMB44 million on higher CanCatch test volumes, while in-hospital revenue increased 17% to RMB51 million driven by higher sales volume from existing hospitals and new contracted partner hospitals. For FY 2025, revenue increased 5% to RMB539.57 million and net loss narrowed to RMB55.35 million. FY 2025 pharma research and development services revenue rose 35% to RMB155.5 million on increased development and testing services for pharma customers, while cash, cash equivalents and restricted cash totaled RMB481.09 million as of Dec. 31, 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/BNR\">Burning Rock Biotech</a> Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603120708PRIMZONEFULLFEED9670857) on March 12, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Burning Rock Q4 net loss narrows 81% to RMB15.4 million as cost of revenues falls 24% to RMB27.7 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBurning Rock Q4 net loss narrows 81% to RMB15.4 million as cost of revenues falls 24% to RMB27.7 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-12 19:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Burning Rock Q4 net loss narrows 81% to RMB15.4 million as cost of revenues falls 24% to RMB27.7 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Burning Rock reported Q4 2025 revenue of RMB126.3 million, up 10% in gross profit to RMB98.57 million. Q4 net loss narrowed to RMB15.4 million from a year earlier, while operating expenses fell 36% to RMB110.6 million due to budget control measures including headcount reduction. In Q4, central laboratory revenue rose 12% to RMB44 million on higher CanCatch test volumes, while in-hospital revenue increased 17% to RMB51 million driven by higher sales volume from existing hospitals and new contracted partner hospitals. For FY 2025, revenue increased 5% to RMB539.57 million and net loss narrowed to RMB55.35 million. FY 2025 pharma research and development services revenue rose 35% to RMB155.5 million on increased development and testing services for pharma customers, while cash, cash equivalents and restricted cash totaled RMB481.09 million as of Dec. 31, 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/BNR\">Burning Rock Biotech</a> Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603120708PRIMZONEFULLFEED9670857) on March 12, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B64PRP62.GBP","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL8rLNNz:1","article_id":"2618411136","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618411136","pubTimestamp":1773313794,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Burning Rock reported Q4 2025 revenue of RMB126.3 million, up 10% in gross profit to RMB98.57 million. Q4 net loss narrowed to RMB15.4 million from a year earlier, while operating expenses fell 36% to RMB110.6 million due to budget control measures including headcount reduction. In Q4, central laboratory revenue rose 12% to RMB44 million on higher CanCatch test volumes, while in-hospital revenue increased 17% to RMB51 million driven by higher sales volume from existing hospitals and new contracted partner hospitals. For FY 2025, revenue increased 5% to RMB539.57 million and net loss narrowed to RMB55.35 million. FY 2025 pharma research and development services revenue rose 35% to RMB155.5 million on increased development and testing services for pharma customers, while cash, cash equivalents and restricted cash totaled RMB481.09 million as of Dec. 31, 2025.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","BK4112":"金融交易所和数据","NDAQ":"纳斯达克OMX交易所","BNR":"燃石医学","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4588":"碎股","BK4139":"生物科技","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4585":"ETF&股票定投概念","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD"},"translate_title":"Burning Rock第四季度净亏损收窄81%至人民币1,540万元，收入成本下降24%至人民币2,770万元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"BNR":0.9},"content_text":"Burning Rock Q4 net loss narrows 81% to RMB15.4 million as cost of revenues falls 24% to RMB27.7 million\n    \n\n        Burning Rock reported Q4 2025 revenue of RMB126.3 million, up 10% in gross profit to RMB98.57 million. Q4 net loss narrowed to RMB15.4 million from a year earlier, while operating expenses fell 36% to RMB110.6 million due to budget control measures including headcount reduction. In Q4, central laboratory revenue rose 12% to RMB44 million on higher CanCatch test volumes, while in-hospital revenue increased 17% to RMB51 million driven by higher sales volume from existing hospitals and new contracted partner hospitals. For FY 2025, revenue increased 5% to RMB539.57 million and net loss narrowed to RMB55.35 million. FY 2025 pharma research and development services revenue rose 35% to RMB155.5 million on increased development and testing services for pharma customers, while cash, cash equivalents and restricted cash totaled RMB481.09 million as of Dec. 31, 2025.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Burning Rock Biotech Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603120708PRIMZONEFULLFEED9670857) on March 12, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618411136","isCrawlerRequest":true}